UBX

Unity Biotechnology

Delisted

UBX was delisted on the 8th of July, 2025.

42 hedge funds and large institutions have $8.4M invested in Unity Biotechnology in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

7.6% more ownership

Funds ownership: 18.32%25.93% (+7.6%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.63M
Puts
$32K
Net Calls
Net Calls Change

Top Buyers

1 +$1.94M
2 +$1.33M
3 +$93.9K
4
Morgan Stanley
Morgan Stanley
New York
+$82.7K
5
XT
XTX Topco
Cayman Islands
+$40.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.01M
2
$1.94M
3
$1.33M
4
$1.08M
5
$254K
6
$239K
7
$218K
8
$179K
9
$142K
10
$96.5K
11
$94.9K
12
$93.9K
13
$84K
14
$79.6K
15
$74K
16
$73K
17
$54.9K
18
$49.2K
19
$46K
20
$41.8K
21
$41.6K
22
$40.5K
23
$30.8K
24
$25.9K
25
$25.5K